Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease c1 inhibitor deficiency
Symptom C0019243|hereditary angioedema
Sentences 28
PubMedID- 26429506 hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) is the best characterized form of hereditary angioedema.
PubMedID- 24996814 Background: hereditary angioedema (hae) due to c1 inhibitor deficiency is a rare but serious and potentially life-threatening disease marked by spontaneous, recurrent attacks of swelling.
PubMedID- 22817696 Background: there is a need for a disease-specific instrument for assessing health-related quality of life in adults with hereditary angioedema due to c1 inhibitor deficiency, a rare, disabling and life-threatening disease.
PubMedID- 25669442 Recombinant human c1 esterase inhibitor for the treatment of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae).
PubMedID- 26535898 hereditary angioedema due to c1 inhibitor deficiency in serbia: two novel mutations and evidence of genotype-phenotype association.
PubMedID- 20818886 Background: hereditary angioedema due to c1 inhibitor deficiency is characterized by recurrent acute attacks of swelling that can be painful and sometimes life-threatening.
PubMedID- 23653967 Background: hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) has considerable implications for dental health care providers, since dental procedures may trigger severe and even life-threatening episodes.
PubMedID- 21760740 Ecallantide is a novel treatment for attacks of hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 26016741 Background: hereditary angioedema (hae) due to c1 inhibitor deficiency manifests as recurrent swelling attacks that can be disabling and sometimes fatal.
PubMedID- 22909164 Background: hereditary angioedema (hae) owing to c1 inhibitor deficiency is an autosomal dominant disorder, characterized by recurrent, potentially life-threatening, localized attacks of tissue swelling.
PubMedID- 20664282 Background: hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) is characterized by recurrent edema attacks in various organs.
PubMedID- 23937903 hereditary angioedema with c1 inhibitor deficiency: delay in diagnosis in europe.
PubMedID- 25475444 Background: danazol, a drug extensively used in the management of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae), has various side effects.
PubMedID- 25758562 A nationwide survey of hereditary angioedema due to c1 inhibitor deficiency in italy.
PubMedID- 22288585 The autoreactivity of b cells in hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 25924832 Background: attacks of hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) are commonly treated in the emergency department.
PubMedID- 21601496 Objective: tooth extractions may trigger clinical symptoms of hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh).
PubMedID- 20804470 Mutational spectrum and phenotypes in danish families with hereditary angioedema because of c1 inhibitor deficiency.
PubMedID- 25054967 Context and objective: hereditary angioedema (hae) with c1 inhibitor deficiency manifests as recurrent episodes of edema involving the skin, upper respiratory tract and gastrointestinal tract.
PubMedID- 26304015 Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 26250409 Recombinant replacement therapy for hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 22841766 Background: hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) is characterized by relapsing skin swellings, abdominal pain attacks, and, less frequently, potentially life-threatening laryngeal attacks.
PubMedID- 24411585 hereditary angioedema (hae) due to c1 inhibitor deficiency is a rare disease characterized by attacks of edema, known to impact quality of life (qol).
PubMedID- 26154504 hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) is a rare autosomal dominant disease with an uncertain prevalence estimated to be 1: 50 000 1 and is caused by mutation in the serping1 gene.
PubMedID- 22677048 Update in hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 24054366 hereditary angioedema with c1 inhibitor deficiency: clinical presentation and quality of life of 193 french patients.
PubMedID- 26512744 Areas covered: the aim of this review article is to present current available therapies for treatment of acute attacks as well as for short- and long-term prophylaxis of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae).
PubMedID- 23634741 Therapeutic management of hereditary angioedema due to c1 inhibitor deficiency.

Page: 1